Skip to main content
. 2019 Feb 12;4(4):332–340. doi: 10.1001/jamacardio.2019.0325

Figure 3. Long-term Survival Following Femoropopliteal Artery Revascularization With Drug-Coated Devices Compared With Non–Drug-Coated Devices Among Patients Without Critical Limb Ischemia.

Figure 3.

Displayed are the cumulative incidence curves for all-cause mortality after femoropopliteal artery revascularization among patients without critical limb ischemia, stratified by treatment with drug-coated devices (drug) vs non–drug-coated devices (nondrug) (A), drug-coated balloons (DCB) vs uncoated balloons (PTA) (B), and drug-eluting stents (DES) vs bare metal stents (BMS) (C).